-
Psychedelic Therapy Boosted By 3D Movement Data? This Company Is Aiming To Patent The Combination
Wednesday, December 7, 2022 - 2:47pm | 547Canadian magic mushrooms and truffles producer Red Light Holland Corp. (OTC: TRUFF)’s wholly-owned subsidiary, health tech firm Radix Motion Inc., has received an International Preliminary Report on Patentability for its patent application on 3D movement data usage in...
-
Psychedelics Production Methods Expect Further IP Protection With 4 New Patents
Wednesday, December 7, 2022 - 2:02pm | 336Biotech company PsyBio Therapeutics Corp. (OTCQB: PSYBF) has filed four new U.S. Patent Cooperation Treaty (PCT) applications aiming to convert five provisional patent applications. These new filings bring the total number of PCT conversion filings completed by the company to 10. They “...
-
LSD Research Ramps Up: Full-Dose & Microdosing For Alzheimer's Studies Led By Beckley Foundation Coming Soon
Monday, November 21, 2022 - 2:09pm | 830The Beckley Foundation and its founder and long-time psychedelics researcher Amanda Feilding announced a new research program involving a pioneering study with King's College London and UCL on the effects of full dose LSD as well as a breakthrough study with the University...
-
Psychedelic Therapeutics For Human Stroke: Participant Screening Expects To Begin Soon
Wednesday, November 16, 2022 - 1:47pm | 378Canadian clinical-stage psychedelics company Algernon Pharmaceuticals Inc. (OTCQB: AGNPF) has begun screening subjects for its Phase 1 clinical study on the IV formulation of its DMT compound AP-188 in the Netherlands. CEO Christopher J. Moreau said the company is thrilled to initiate...
-
Reunion Neuroscience Presents Q2 2023 Financial Results & Pipeline Update
Monday, November 14, 2022 - 3:58pm | 674Psychedelics biopharma company Reunion Neuroscience Inc. (NASDAQ: REUN) reported its business update and fiscal results for the second quarter ended September 30, 2022. Reunion’s president and CEO Greg Mayes stated that the company has consolidated as an independent company and is “well...
-
Elon Musk Joins Twitter Conversation About Psychedelics: A Debate On Empathy
Monday, November 14, 2022 - 2:32pm | 660Elon Musk continues touting the benefits of psychedelics, from his live interview at CodeCon2021 to his most recent tweets endorsing those working towards developing these substances for better therapeutic effects and even revisiting his own experience with them. Tesla (NASDAQ:...
-
Filament Health Shares Q3 2022 Results, On Road To Becoming Industry's Natural Psilocybin Supplier
Friday, November 11, 2022 - 3:45pm | 377Clinical-stage natural psychedelic drug development company Filament Health Corp. (OTCQB: FLHLF) reported its third quarter financial results and operational highlights for the period ended September 30, 2022. Numbers show total cash was over $2.6 million (CA$3.5 million), compared to $3.47...
-
COMPASS Pathways Shares Q3 2022 Financial Results, Business News & Term's Highlights
Friday, November 4, 2022 - 5:51pm | 572Psychedelics mental healthcare firm COMPASS Pathways (NASDAQ: CMPS) reported its financial outcomes for the third quarter ended 30 September 2022 and gave an update on its most recent pipeline and business developments. Numbers on 30 September 2022 show: Cash and cash equivalents totaled $...
-
Psychedelics Company Launches New Supplements Line, Joins Global Wellness Market
Friday, November 4, 2022 - 2:25pm | 386Mental health company Revitalist Lifestyle and Wellness Ltd. (OTCQB: RVLWF) is consolidating its presence in the expanding global market of plant-based psychedelic medicines and additional enhancing products with the release of a novel supplement product line called Vital+. Formulated to...
-
New York Update: Will Psychedelics Achieve Legal Status In 2023? Details On A Newly Amended Bill
Friday, October 7, 2022 - 2:16pm | 285Democratic Assemblymember Linda Rosenthal's 2021 psychedelics bill was intended to delist psilocybin and psilocin as Schedule I substances. Nonetheless, on October 3, 2022, that same bill with additional stipulations broadening legal protection of adults possessing and using several...
-
Can Ketamine Treat Alcohol Addiction? This Is How Therapy Actually Functions
Monday, October 3, 2022 - 12:10pm | 751(Part two of a four-part series, see part one here) Dr. Ben Sessa, cofounder and head of psychedelic medicine at Awakn Life Sciences (OTC: AWKNF) explained that scientific evidence shows ketamine creates neurogenesis: “You actually have growth of nervous tissue. You can...
-
Can Ketamine Treat Alcohol Addiction? Clinics & Hospitals In Europe And North America Are Already Doing It
Friday, September 30, 2022 - 9:44am | 697(Part one of a four-part series) The use of psychedelic-assisted psychotherapy for the treatment of mental health conditions has become a hot topic, with a growing general sense of acceptance, public discussion and reform. Each compound is proven to have specific characteristics,...
-
Clinical Study On DMT Inhaled Product For Treatment-Resistant Depression Completes Dosing Stage
Friday, September 23, 2022 - 4:30pm | 296Biomind Labs Inc. (OTC: BMNDF), a life sciences company developing medicinal next-generation psychedelics, completed the dose administration of 30 healthy subjects within its Phase 2 clinical trial of DMT-based proprietary drug BMND01 for the Treatment-Resistant Depression (TDR) disorder. Besides...
-
Magic Mushrooms Producer Optimi Keeps Betting On The FDA-approval Of Psychedelics
Thursday, September 1, 2022 - 3:56pm | 610Optimi Health (OTCQX: OPTHF) has released an operational update on its planned year of commercialization, including the launch of psychedelics catalog. Optimi is licensed by Health Canada as a producer and supplier of natural GMP psilocybin and synthetic psychedelic substances....
-
First International Psilocybin Supply Agreement For Optimi Health: Here Are The Details
Tuesday, August 30, 2022 - 7:53pm | 647Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a Canadian-based company licensed by Health Canada to produce and supply natural psilocybin and other psychedelic substances, announced that it has entered into its first international psilocybin supply agreement with Promises...